PRMT1 and hepatocellular carcinoma: In conclusion, our findings indicate that PRMTs are predicted to be novel prognostic markers for HCC, and PRMT1 may perform significant effects on HCC development via Tex regulation, suggesting that targeting PRMT1 and PRMT1-positive Tex may be effective HCC therapies.